| The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21. 1 losses in malignant pleural mesothelioma M Bott, M Brevet, BS Taylor, S Shimizu, T Ito, L Wang, J Creaney, RA Lake, ... Nature genetics 43 (7), 668-672, 2011 | 773 | 2011 |
| The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 378 | 2020 |
| NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination M Ruscetti, J Leibold, MJ Bott, M Fennell, A Kulick, NR Salgado, CC Chen, ... Science 362 (6421), 1416-1422, 2018 | 285 | 2018 |
| Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers JX Caushi, J Zhang, Z Ji, A Vaghasia, B Zhang, EHC Hsiue, BJ Mog, ... Nature 596 (7870), 126-132, 2021 | 280 | 2021 |
| Initial results of pulmonary resection after neoadjuvant nivolumab in patients with resectable non–small cell lung cancer MJ Bott, SC Yang, BJ Park, PS Adusumilli, VW Rusch, JM Isbell, ... The Journal of thoracic and cardiovascular surgery 158 (1), 269-276, 2019 | 250 | 2019 |
| Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer JM Chan, A Quintanal-Villalonga, VR Gao, Y Xie, V Allaj, O Chaudhary, ... Cancer cell 39 (11), 1479-1496. e18, 2021 | 183 | 2021 |
| Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung adenocarcinoma: a propensity score–matched analysis T Eguchi, K Kameda, S Lu, MJ Bott, KS Tan, J Montecalvo, JC Chang, ... Journal of thoracic oncology 14 (1), 87-98, 2019 | 180 | 2019 |
| Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma NP Chudgar, MF Brennan, RR Munhoz, PR Bucciarelli, KS Tan, ... The Journal of thoracic and cardiovascular surgery 154 (1), 319-330. e1, 2017 | 111 | 2017 |
| Safety and feasibility of lung resection after immunotherapy for metastatic or unresectable tumors MJ Bott, J Cools-Lartigue, KS Tan, J Dycoco, MS Bains, RJ Downey, ... The Annals of thoracic surgery 106 (1), 178-183, 2018 | 110 | 2018 |
| New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment M Ladanyi, MG Zauderer, LM Krug, T Ito, R McMillan, M Bott, F Giancotti Clinical Cancer Research 18 (17), 4485-4490, 2012 | 110 | 2012 |
| Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations MG Zauderer, M Bott, R McMillan, CS Sima, V Rusch, LM Krug, M Ladanyi Journal of Thoracic Oncology 8 (11), 1430-1433, 2013 | 104 | 2013 |
| Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of … M Grillo, MJ Bott, N Khandke, JP McGinnis, M Miranda, M Meyyappan, ... Breast cancer research and treatment 95, 185-194, 2006 | 103 | 2006 |
| Shape-sensing robotic-assisted bronchoscopy in the diagnosis of pulmonary parenchymal lesions O Kalchiem-Dekel, JG Connolly, IH Lin, BC Husta, PS Adusumilli, ... Chest 161 (2), 572-582, 2022 | 101 | 2022 |
| The underlying tumor genomics of predominant histologic subtypes in lung adenocarcinoma R Caso, F Sanchez-Vega, KS Tan, B Mastrogiacomo, J Zhou, GD Jones, ... Journal of Thoracic Oncology 15 (12), 1844-1856, 2020 | 97 | 2020 |
| Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intrapulmonary metastases: comparison with standard histopathologic … JC Chang, D Alex, M Bott, KS Tan, V Seshan, A Golden, JL Sauter, ... Clinical Cancer Research 25 (23), 7113-7125, 2019 | 74 | 2019 |
| Early quality of life outcomes after robotic-assisted minimally invasive and open esophagectomy IS Sarkaria, NP Rizk, DA Goldman, C Sima, KS Tan, MS Bains, ... The Annals of thoracic surgery 108 (3), 920-928, 2019 | 69 | 2019 |
| Pathologic upstaging in patients undergoing resection for stage I non-small cell lung cancer: are there modifiable predictors? MJ Bott, AP Patel, TD Crabtree, GA Colditz, D Kreisel, AS Krupnick, ... The Annals of thoracic surgery 100 (6), 2048-2053, 2015 | 69 | 2015 |
| Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy M Brevet, S Shimizu, MJ Bott, N Shukla, Q Zhou, AB Olshen, V Rusch, ... Journal of Thoracic Oncology 6 (5), 864-874, 2011 | 67 | 2011 |
| Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability PL Wagner, E McAleer, E Stillwell, M Bott, VW Rusch, W Schaffer, ... The Journal of thoracic and cardiovascular surgery 141 (1), 34-38, 2011 | 67 | 2011 |
| A genomic-pathologic annotated risk model to predict recurrence in early-stage lung adenocarcinoma GD Jones, WS Brandt, R Shen, F Sanchez-Vega, KS Tan, A Martin, ... JAMA surgery 156 (2), e205601-e205601, 2021 | 56 | 2021 |
